NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
192 hedge funds and large institutions have $3.02B invested in NEVRO CORP. in 2016 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 60 increasing their positions, 74 reducing their positions, and 23 closing their positions.
78% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 23
43% more capital invested
Capital invested by funds: $2.11B → $3.02B (+$909M)
10% more funds holding
Funds holding: 175 → 192 (+17)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
15% less call options, than puts
Call options by funds: $21.3M | Put options by funds: $25.1M
19% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 74
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$49.4M |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$48.7M |
| 3 |
DM
Deerfield Management
New York
|
+$48.4M |
| 4 |
O
OppenheimerFunds
New York
|
+$37.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$29.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$96.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$36.5M |
| 3 |
PA
Perceptive Advisors
New York
|
-$31.9M |
| 4 |
BC
Broadfin Capital
New York
|
-$30.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$30.8M |
NVRO Hedge Fund Activity: Q3 2016 in Review
192 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2016, worth a combined $3.02B — up 43% from $2.11B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NVRO positions and 23 closed out — a net gain of 18 holders — while 60 added to existing stakes and 74 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $49.4M. The largest seller was Wells Fargo, cutting an estimated $96.7M.
- 192 institutional investors held NEVRO CORP. (NVRO) as of Q3 2016, up from 175 in Q2 2016.
- Funds reported $3.02B of NEVRO CORP. stock for Q3 2016, up 43% quarter-over-quarter.
- 41 funds opened new NEVRO CORP. positions in Q3 2016 and 23 closed out, a net change of +18 holders.
- The largest NEVRO CORP. buyer in Q3 2016 was Goldman Sachs, an estimated $49.4M added.
- The largest NEVRO CORP. seller in Q3 2016 was Wells Fargo, an estimated $96.7M sold.
Based on aggregated 13F filings for Q3 2016.